Share

Aegerion CEO on Promise of Biopharma

Marc Beer, Aegerion Pharmaceuticals CEO, discusses a drug in the company's portfolio that treats patients with severe cholesterol disorder.
05:04
Wed, Jan 23 20136:43 AM EST